Endobronchial ultrasound and bronchial artery embolization for Dieulafoy's disease of the bronchus in a teenager: A case report

Ganganah, Oormila; Guo, Shuliang; Chiniah, Manu; Sah, Shambhu Kumar; Wu, Jinxing

doi:10.1016/j.rmcr.2015.04.007

Cited by 22 publications

(25 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Four patients were shown to have vascular malformations under mucosal protrusion by endobronchial ultrasound scan (EBUS) [11,21,32,44]. EBUS bronchoscopes with integrated probes at the distal ends usually have a Doppler mode and can be used to differentiate vascular from solid endobronchial masses, and therefore may help avoid potentially disastrous interventions [47,48].…”

Section: Discussionmentioning

confidence: 99%

“…According to this study, 52.6% patients who underwent first-line BAE required lobectomy due to BAE failure or a subsequent recurrence. The poor efficacy of BAE in this situation has been attributed to revascularization and neoangiogenesis at the site of therapeutic embolization or hypertrophy of nearby submucosal vasculature creating recurrences after successful procedures [28,38], broncho-pulmonary shunts [11], and an aberrant pulmonary artery instead of a bronchial artery [2]. Patients with Dieulafoy's disease treated with embolotherapy may develop a recurrence, hence should be under regular follow-up care [28].…”

Section: Discussionmentioning

confidence: 99%

“…Most of the cases were reported from Asia (38 patients) [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24], followed by Europe (23 patients) [3,4,[25][26][27][28][29][30][31][32][33][34][35][36][37], North America (seven patients) [38][39][40][41][42][43][44], Oceania (two patients) [5,45], and the country of origin was not reported for three patients (Fig. 2) [46].…”

Section: Continent and Country Of Originmentioning

confidence: 99%

See 2 more Smart Citations

Bronchial Dieulafoy’s disease: a retrospective analysis of 73 cases

Qian

Wei

et al. 2019

BMC Pulm Med

View full text Add to dashboard Cite

Background Bronchial Dieulafoy’s disease (BDD) is a rare disease that is known to be a cause of hemorrhage. The characteristics of this disease are still unknown. The present study describes the disorder based on a review of the world’s literature, emphasizing the diagnostic and therapeutic views. Methods A comprehensive research of BDD of the PubMed, Google Scholar, and Web of Science databases was performed. The following data were collected: patient characteristics; chest imaging, bronchoscopy, vascular angiography, and histopathologic examination findings; and treatment rendered. Results 73 cases of BDD have been reported from 1995 to 2019. Most of the cases occurred in Asia (52.1%), followed by Europe (31.5%). Chest imaging findings were non-specific. The main bronchoscopy finding was a nodular or protruding lesion (60.9%). 19 patients underwent bronchoscopic biopsies, 17 had bleeding, and 6 died. Four patients were successfully shown to have vascular malformations under mucosal protrusion by endobronchial ultrasound scan (EBUS). Vascular angiography mainly showed tortuous, dilated bronchial arteries. Vascular angiography mainly showed tortuous, dilated bronchial arteries. The arterial supply was mainly provided by bronchial arteries (48 cases) and the pulmonary circulation (4 cases). The lesions were mainly located in the right bronchus (53 cases). Selective bronchial artery embolization (BAE) was attempted in 38 patients and 20 patients underwent lobectomies. Emergency resection was performed in 15 patients, all of whom survived and had no recurrent hemoptysis. Conclusions Massive hemoptysis was the common manifestation of BDD. Vascular angiography and EBUS is a very useful examination before biopsy. BAE may be used in stable patients, or patients who cannot tolerate surgery, while surgical resection should be considered in patients who are unstable, patients with uncontrolled hemoptysis, or following BAE failure. Electronic supplementary material The online version of this article (10.1186/s12890-019-0863-1) contains supplementary material, which is available to authorized users.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Continent and Country Of Originmentioning

confidence: 99%

See 1 more Smart Citation

Bronchial Dieulafoy’s disease: a retrospective analysis of 73 cases

Qian

Wei

et al. 2019

BMC Pulm Med

View full text Add to dashboard Cite

show abstract

“…To patients who failing endoscopic therapy, angiography with gel foam embolization should be suggested [18]. Surgical management, regarded as the only treatment initially available before, is reserved for patients who are refractory to endoscopy and angiography.…”

Section: Discussionmentioning

confidence: 99%

Ten- Year-Old Female with Dieulafoy Lesion Treated with Therapeutic Endoscopy And Literature Review

Chen

Sun

2020

Preprint

View full text Add to dashboard Cite

Background There are many causes of sudden gastrointestinal bleeding in children, Dieulafoy lesion is very rare. This vascular abnormality can be fatal without appropriate treatment.Case presentation Retrospective analysis of the clinical manifestations, endoscopic features and treatment of a Chinese child with Dieulafoy lesion and review relevant literatures.Result A 10-year-old girl was admitted to hospital with sudden massive hematemesis and melena. Abdominal CT revealed suspected submucosal bleeding in the stomach. Finally the disease was diagnosed due to the typical manifestations with endoscopy. Meanwhile, we used electrocoagulation and hemoclips to hemostasis under endoscopy. No recurrence of hematemesis identified during the 4-weeks follow-up.Conclusion Dieulafoy lesion in children is rare cause of sudden gastrointestinal hemorrhage. But differential diagnosis cannot ignore it. Endoscope is the optimize choice for diagnosis and treatment.

show abstract

“…[2] The respiratory tract is an extremely rare site of involvement, and only a few case reports describe bronchial Dieulafoy's disease. [3] The presentation is usually in adulthood with one or more episodes of hemoptysis, which may be massive. Conventional management options that have been described for bronchial Dieulafoy's disease include surgical resection and selective arteriographic embolization.…”

Section: Introductionmentioning

confidence: 99%

Flexible bronchoscopic argon plasma coagulation for management of massive hemoptysis in bronchial Dieulafoy's disease

et al. 2017

View full text Add to dashboard Cite

Dieulafoy's disease is an uncommon condition, the usual site of occurrence being the gastrointestinal tract. The condition refers to the presence of a dysplastic submucosal artery with mucosal vascular branches that has propensity to cause recurrent bleeding. Dieulafoy's disease of the bronchus is rare. Herein, we describe the case of a 26-year-old male who presented with recurrent bouts of hemoptysis and bronchial Dieulafoy's disease was diagnosed. Flexible bronchoscopy was performed, and argon plasma coagulation (APC) of the bleeding lesion was done. The procedure was successful and was followed by complete eradication of the vascular malformation and cessation of hemoptysis. APC is a useful tool in the armamentarium of an interventional pulmonologist that can allow rapid and safe control of bleeding from superficially located and bleeding endobronchial lesions, and can be easily and effectively applied using a flexible bronchoscope.

show abstract

Endobronchial ultrasound and bronchial artery embolization for Dieulafoy's disease of the bronchus in a teenager: A case report

Cited by 22 publications

References 13 publications

Bronchial Dieulafoy’s disease: a retrospective analysis of 73 cases

Bronchial Dieulafoy’s disease: a retrospective analysis of 73 cases

Ten- Year-Old Female with Dieulafoy Lesion Treated with Therapeutic Endoscopy And Literature Review

Flexible bronchoscopic argon plasma coagulation for management of massive hemoptysis in bronchial Dieulafoy's disease

Contact Info

Product

Resources

About